Literature DB >> 7850764

Lung cancer pathology in smokers, ex-smokers and never smokers.

J E Muscat1, E L Wynder.   

Abstract

The histologic distribution of lung cancer is markedly different in smokers and non-smokers. It is not known whether the histology among former smokers varies according to the number of years since quitting. Using data from a large case-control study of lung cancer, we found that for both men and women, the proportion of adenocarcinomas increased with the number of years since quitting smoking. Among long-term quitters (> 25 years), the proportion of adenocarcinomas was similar to that in never smokers. These findings have implications for studies of environmental tobacco smoke and lung cancer.

Entities:  

Mesh:

Year:  1995        PMID: 7850764     DOI: 10.1016/0304-3835(94)03608-l

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  18 in total

Review 1.  Sex-specific lung diseases: effect of oestrogen on cultured cells and in animal models.

Authors:  Bosung Shim; Gustavo Pacheco-Rodriguez; Jiro Kato; Thomas N Darling; Martha Vaughan; Joel Moss
Journal:  Eur Respir Rev       Date:  2013-09-01

Review 2.  Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer.

Authors:  Peter N Lee; Barbara A Forey; Katharine J Coombs
Journal:  BMC Cancer       Date:  2012-09-03       Impact factor: 4.430

3.  Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO).

Authors:  Claire H Kim; Yuan-Chin Amy Lee; Rayjean J Hung; Sheila R McNallan; Michele L Cote; Wei-Yen Lim; Shen-Chih Chang; Jin Hee Kim; Donatella Ugolini; Ying Chen; Triantafillos Liloglou; Angeline S Andrew; Tracy Onega; Eric J Duell; John K Field; Philip Lazarus; Loic Le Marchand; Monica Neri; Paolo Vineis; Chikako Kiyohara; Yun-Chul Hong; Hal Morgenstern; Keitaro Matsuo; Kazuo Tajima; David C Christiani; John R McLaughlin; Vladimir Bencko; Ivana Holcatova; Paolo Boffetta; Paul Brennan; Eleonora Fabianova; Lenka Foretova; Vladimir Janout; Jolanta Lissowska; Dana Mates; Peter Rudnai; Neonila Szeszenia-Dabrowska; Anush Mukeria; David Zaridze; Adeline Seow; Ann G Schwartz; Ping Yang; Zuo-Feng Zhang
Journal:  Int J Cancer       Date:  2014-03-25       Impact factor: 7.396

4.  Estrogen receptor signaling in lung cancer.

Authors:  Jill M Siegfried; Pamela A Hershberger; Laura P Stabile
Journal:  Semin Oncol       Date:  2009-12       Impact factor: 4.929

Review 5.  Challenging the epidemiologic evidence on passive smoking: tactics of tobacco industry expert witnesses.

Authors:  John A Francis; Amy K Shea; Jonathan M Samet
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

6.  Lung cancer incidence in never smokers.

Authors:  Heather A Wakelee; Ellen T Chang; Scarlett L Gomez; Theresa H Keegan; Diane Feskanich; Christina A Clarke; Lars Holmberg; Lee C Yong; Laurence N Kolonel; Michael K Gould; Dee W West
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

7.  Calibration of disease simulation model using an engineering approach.

Authors:  Chung Yin Kong; Pamela M McMahon; G Scott Gazelle
Journal:  Value Health       Date:  2009-01-12       Impact factor: 5.725

Review 8.  The Daniel K. Inouye College of Pharmacy Scripts: Targeted Nanocarrier Based Systems for the Treatment of Lung Cancer.

Authors:  Susanne R Youngren-Ortiz; Mahavir B Chougule
Journal:  Hawaii J Med Public Health       Date:  2017-11

9.  Histological subtypes of lung cancer in Chinese women from 2000 to 2012.

Authors:  Xiao Nong Zou; Dongmei Lin; Ann Chao; Xia Wan; Qinfu Feng; Junling Li; Jie Yang; Gong Huan Yang; Ning Lv
Journal:  Thorac Cancer       Date:  2014-08-25       Impact factor: 3.500

10.  Opposing functions of Akt isoforms in lung tumor initiation and progression.

Authors:  Nicolle M Linnerth-Petrik; Lisa A Santry; James J Petrik; Sarah K Wootton
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.